SMC cannot recommend venlafaxine extended release capsules (Efexor XL) for generalised social anxiety disorder/social phobia due to non-submission

Reference: 501/08

Source: Scottish Medicines Consortium (SMC)

Date published: 11/08/2008 16:33

Summary
by: Nicola Pocock

In the absence of a submission from the holder of the marketing authorisation, the Scottish Medicines Consortium (SMC) is unable to recommend venlafaxine extended release capsules (Efexor XL) for use within NHSScotland for the treatment of moderate to severe generalised social anxiety disorder/social phobia in adults.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.